Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Clearside Biomedical, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 53 | 51 | −2 |
| Shares | 9.13M | 8.75M | −387.6K (−4.2%) |
| Value | $10.2M | $9.09M | −$1.14M (−11.1%) |
New holders (9)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janney Montgomery Scott LLC | 100,000 | $104.0K | 0.00% |
| Stratos Wealth Partners, LTD. | 25,180 | $26.2K | 0.00% |
| Captrust Financial Advisors | 21,006 | $21.8K | 0.00% |
| Golden State Equity Partners | 19,780 | $20.6K | 0.01% |
| Asset Management Corp | 14,000 | $14.6K | 0.01% |
| Baader Bank INC | 13,814 | $11.2K | 0.00% |
| UBS Group AG | 6,158 | $6.40K | 0.00% |
| Group One Trading, L.P. | 1,587 | $1.65K | 0.00% |
| Tower Research Capital LLC (TRC) | 64 | $0 | 0.00% |
Sold out (11)
Institutions that held Clearside Biomedical, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Franklin Resources Inc | 76,717 | $85.9K |
| Hamilton Lane Advisors LLC | 65,359 | $73.0K |
| Ergoteles LLC | 54,849 | $61.4K |
| Millennium Management LLC | 53,814 | $60.0K |
| Bailard, Inc. | 47,800 | $53.5K |
| Ameritas Advisory Services, LLC | 41,620 | $46.6K |
| NewEdge Wealth, LLC | 30,000 | $33.6K |
| Jane Street Group, LLC | 14,232 | $15.9K |
| Two Sigma Securities, LLC | 11,072 | $12.4K |
| Merit Financial Group, LLC | 11,000 | $12.3K |
| Citigroup Inc | 752 | $842 |